Literature DB >> 33800917

Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM).

Rolf Teschke1, Gaby Danan2.   

Abstract

Causality assessment in liver injury induced by drugs and herbs remains a debated issue, requiring innovation and thorough understanding based on detailed information. Artificial intelligence (AI) principles recommend the use of algorithms for solving complex processes and are included in the diagnostic algorithm of Roussel Uclaf Causality Assessment Method (RUCAM) to help assess causality in suspected cases of idiosyncratic drug-induced liver injury (DILI) and herb-induced liver injury (HILI). From 1993 until the middle of 2020, a total of 95,865 DILI and HILI cases were assessed by RUCAM, outperforming by case numbers any other causality assessment method. The success of RUCAM can be traced back to its quantitative features with specific data elements that are individually scored leading to a final causality grading. RUCAM is objective, user friendly, transparent, and liver injury specific, with an updated version that should be used in future DILI and HILI cases. Support of RUCAM was also provided by scientists from China, not affiliated to any network, in the results of a scientometric evaluation of the global knowledge base of DILI. They highlighted the original RUCAM of 1993 and their authors as a publication quoted the greatest number of times and ranked first in the category of the top 10 references related to DILI. In conclusion, for stakeholders involved in DILI and HILI, RUCAM seems to be an effective diagnostic algorithm in line with AI principles.

Entities:  

Keywords:  CAM; Roussel Uclaf Causality Assessment Method (RUCAM); artificial intelligence (AI); diagnostic algorithm; herb-induced liver injury (HILI); idiosyncratic drug-induced liver injury (DILI); quantitative RUCAM

Year:  2021        PMID: 33800917      PMCID: PMC7999240          DOI: 10.3390/diagnostics11030458

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  65 in total

1.  Predicting the graft survival for heart-lung transplantation patients: an integrated data mining methodology.

Authors:  Asil Oztekin; Dursun Delen; Zhenyu James Kong
Journal:  Int J Med Inform       Date:  2009-06-03       Impact factor: 4.046

Review 2.  Artificial intelligence and deep learning - Radiology's next frontier?

Authors:  Ray Cody Mayo; Jessica Leung
Journal:  Clin Imaging       Date:  2017-11-16       Impact factor: 1.605

3.  Diagnostic Algorithms for Cardiovascular Death in Administrative Claims Databases: A Systematic Review.

Authors:  Sonal Singh; Hassan Fouayzi; Kathryn Anzuoni; Leah Goldman; Jea Young Min; Marie Griffin; Carlos G Grijalva; James A Morrow; Christine C Whitmore; Charles E Leonard; Mano Selvan; Vinit Nair; Yunping Zhou; Sengwee Toh; Andrew Petrone; James Williams; Elnara Fazio-Eynullayeva; Richard Swain; D Tyler Coyle; Susan Andrade
Journal:  Drug Saf       Date:  2019-04       Impact factor: 5.606

4.  A reappraisal of Gaucher disease-diagnosis and disease management algorithms.

Authors:  Pramod K Mistry; Maria Domenica Cappellini; Elena Lukina; Hayri Ozsan; Sara Mach Pascual; Hanna Rosenbaum; Maria Helena Solano; Zachary Spigelman; Jesús Villarrubia; Nora Patricia Watman; Gero Massenkeil
Journal:  Am J Hematol       Date:  2011-01       Impact factor: 10.047

5.  An algorithm as a diagnostic tool for central ocular motor disorders, also to diagnose rare disorders.

Authors:  Ludwig Kraus; Olympia Kremmyda; Tatiana Bremova-Ertl; Sebastià Barceló; Katharina Feil; Michael Strupp
Journal:  Orphanet J Rare Dis       Date:  2019-08-08       Impact factor: 4.123

6.  First case of drug-induced liver injury associated with the use of tocilizumab in a patient with COVID-19.

Authors:  Damir Muhović; Jelena Bojović; Ana Bulatović; Batrić Vukčević; Marina Ratković; Ranko Lazović; Brigita Smolović
Journal:  Liver Int       Date:  2020-06-01       Impact factor: 8.754

Review 7.  Liver injury during highly pathogenic human coronavirus infections.

Authors:  Ling Xu; Jia Liu; Mengji Lu; Dongliang Yang; Xin Zheng
Journal:  Liver Int       Date:  2020-03-30       Impact factor: 8.754

8.  What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist's Perspective.

Authors:  Nahum Méndez-Sánchez; Alejandro Valencia-Rodríguez; Xingshun Qi; Eric M Yoshida; Manuel Romero-Gómez; Jacob George; Mohammed Eslam; Ludovico Abenavoli; Weifen Xie; Rolf Teschke; Andres F Carrion; Andrew P Keaveny
Journal:  J Clin Transl Hepatol       Date:  2020-04-11

9.  Liver injury in COVID-19: management and challenges.

Authors:  Chao Zhang; Lei Shi; Fu-Sheng Wang
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-03-04
View more
  4 in total

Review 1.  Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.

Authors:  Rolf Teschke; Nahum Méndez-Sánchez; Axel Eickhoff
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

Review 2.  Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies.

Authors:  Rolf Teschke; Gaby Danan
Journal:  Int J Mol Sci       Date:  2021-03-26       Impact factor: 5.923

3.  The Use of Artificial Intelligence in Complementary and Alternative Medicine: A Systematic Scoping Review.

Authors:  Hongmin Chu; Seunghwan Moon; Jeongsu Park; Seongjun Bak; Youme Ko; Bo-Young Youn
Journal:  Front Pharmacol       Date:  2022-04-01       Impact factor: 5.988

4.  Xiao-Yao-San protects against anti-tuberculosis drug-induced liver injury by regulating Grsf1 in the mitochondrial oxidative stress pathway.

Authors:  Zijun Bai; Weiwei Tao; Yiqun Zhou; Yi Cao; Shun Yu; Zheng Shi
Journal:  Front Pharmacol       Date:  2022-09-01       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.